Fortrea (NASDAQ:FTRE – Get Free Report) is one of 46 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its competitors? We will compare Fortrea to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Analyst Recommendations This is a […]
Mizuho started coverage on shares of Fortrea (NASDAQ:FTRE – Free Report) in a report issued on Tuesday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $27.00 price target on the stock. A number of other equities analysts have also issued reports on the stock. Robert W. Baird raised shares of Fortrea from […]
Fortrea Holdings Inc (NASDAQ:FTRE) CEO Thomas Pike Buys 10,000 Shares modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Fortrea (NASDAQ:FTRE – Free Report) had its price target reduced by Deutsche Bank Aktiengesellschaft from $36.00 to $28.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a hold rating on the stock. A number of other analysts also recently issued reports on the stock. Robert W. Baird upgraded shares […]
Brandes Investment Partners LP bought a new stake in Fortrea Holdings Inc. (NASDAQ:FTRE – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm bought 1,692,160 shares of the company’s stock, valued at approximately $59,056,000. Other hedge funds and other institutional investors also recently made changes to their positions in the company. Boston Partners acquired […]